Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.

Saved in:
Bibliographic Details
Title: Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Authors: van der Straten L; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam-Treatment and Quality of Life, Amsterdam, The Netherlands., Kersting S; Department of Hematology, HAGA Teaching Hospital, The Hague, The Netherlands., Nasserinejad K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dubois J; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Dobber JA; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mellink CHM; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Kevie-Kersemaekers AF; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands., Evers LM; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Koene HR; Department of Hematology, Antonius Hospital, Nieuwegein, The Netherlands., Schreurs J; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Velders GA; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands., van der Straaten HM; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, The Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., van Gelder M; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier The Graaf Hospital, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Visser HPJ; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands., Houtenbos I; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Idink CAM; Department of Internal Medicine, ZorgSaam Hospital, Terneuzen, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands., Dompeling EC; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., van Zaanen HCT; Department of Internal Medicine, St Franciscus Hospital, Rotterdam, The Netherlands., Veelken JH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands., Tick LW; Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands., Terpstra WE; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Langerak AW; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Source: Blood [Blood] 2023 Sep 28; Vol. 142 (13), pp. 1131-1142.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37363833
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+der+Straten+L%22">van der Straten L</searchLink>; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Stege+CAM%22">Stege CAM</searchLink>; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam-Treatment and Quality of Life, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersting+S%22">Kersting S</searchLink>; Department of Hematology, HAGA Teaching Hospital, The Hague, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nasserinejad+K%22">Nasserinejad K</searchLink>; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dubois+J%22">Dubois J</searchLink>; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dobber+JA%22">Dobber JA</searchLink>; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mellink+CHM%22">Mellink CHM</searchLink>; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Kevie-Kersemaekers+AF%22">van der Kevie-Kersemaekers AF</searchLink>; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Evers+LM%22">Evers LM</searchLink>; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Boer+F%22">de Boer F</searchLink>; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koene+HR%22">Koene HR</searchLink>; Department of Hematology, Antonius Hospital, Nieuwegein, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schreurs+J%22">Schreurs J</searchLink>; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Klift+M%22">van der Klift M</searchLink>; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Velders+GA%22">Velders GA</searchLink>; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Spek+E%22">van der Spek E</searchLink>; Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Straaten+HM%22">van der Straaten HM</searchLink>; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogendoorn+M%22">Hoogendoorn M</searchLink>; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Gelder+M%22">van Gelder M</searchLink>; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Posthuma+EFM%22">Posthuma EFM</searchLink>; Department of Internal Medicine, Reinier The Graaf Hospital, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Visser+HPJ%22">Visser HPJ</searchLink>; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Houtenbos+I%22">Houtenbos I</searchLink>; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Idink+CAM%22">Idink CAM</searchLink>; Department of Internal Medicine, ZorgSaam Hospital, Terneuzen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Issa+DE%22">Issa DE</searchLink>; Department of Internal Medicine, Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dompeling+EC%22">Dompeling EC</searchLink>; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Zaanen+HCT%22">van Zaanen HCT</searchLink>; Department of Internal Medicine, St Franciscus Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Veelken+JH%22">Veelken JH</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Levenga+H%22">Levenga H</searchLink>; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tick+LW%22">Tick LW</searchLink>; Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Terpstra+WE%22">Terpstra WE</searchLink>; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tonino+SH%22">Tonino SH</searchLink>; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Westerweel+PE%22">Westerweel PE</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Langerak+AW%22">Langerak AW</searchLink>; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kater+AP%22">Kater AP</searchLink>; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Levin+MD%22">Levin MD</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2023 Sep 28; Vol. 142 (13), pp. 1131-1142.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37363833
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2023020195
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1131
    Titles:
      – TitleFull: Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van der Straten L
      – PersonEntity:
          Name:
            NameFull: Stege CAM
      – PersonEntity:
          Name:
            NameFull: Kersting S
      – PersonEntity:
          Name:
            NameFull: Nasserinejad K
      – PersonEntity:
          Name:
            NameFull: Dubois J
      – PersonEntity:
          Name:
            NameFull: Dobber JA
      – PersonEntity:
          Name:
            NameFull: Mellink CHM
      – PersonEntity:
          Name:
            NameFull: van der Kevie-Kersemaekers AF
      – PersonEntity:
          Name:
            NameFull: Evers LM
      – PersonEntity:
          Name:
            NameFull: de Boer F
      – PersonEntity:
          Name:
            NameFull: Koene HR
      – PersonEntity:
          Name:
            NameFull: Schreurs J
      – PersonEntity:
          Name:
            NameFull: van der Klift M
      – PersonEntity:
          Name:
            NameFull: Velders GA
      – PersonEntity:
          Name:
            NameFull: van der Spek E
      – PersonEntity:
          Name:
            NameFull: van der Straaten HM
      – PersonEntity:
          Name:
            NameFull: Hoogendoorn M
      – PersonEntity:
          Name:
            NameFull: van Gelder M
      – PersonEntity:
          Name:
            NameFull: Posthuma EFM
      – PersonEntity:
          Name:
            NameFull: Visser HPJ
      – PersonEntity:
          Name:
            NameFull: Houtenbos I
      – PersonEntity:
          Name:
            NameFull: Idink CAM
      – PersonEntity:
          Name:
            NameFull: Issa DE
      – PersonEntity:
          Name:
            NameFull: Dompeling EC
      – PersonEntity:
          Name:
            NameFull: van Zaanen HCT
      – PersonEntity:
          Name:
            NameFull: Veelken JH
      – PersonEntity:
          Name:
            NameFull: Levenga H
      – PersonEntity:
          Name:
            NameFull: Tick LW
      – PersonEntity:
          Name:
            NameFull: Terpstra WE
      – PersonEntity:
          Name:
            NameFull: Tonino SH
      – PersonEntity:
          Name:
            NameFull: Westerweel PE
      – PersonEntity:
          Name:
            NameFull: Langerak AW
      – PersonEntity:
          Name:
            NameFull: Kater AP
      – PersonEntity:
          Name:
            NameFull: Levin MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 09
              Text: 2023 Sep 28
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 142
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1